Medicine composition used for cardiovascular disorders
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and cardiovascular technology, applied in cardiovascular system diseases, drug combination, drug delivery and other directions, can solve problems such as difficulty in lowering systolic blood pressure, achieve exact antihypertensive effect, restore blood pressure fluctuation circadian rhythm, and improve myocardial hypertrophy. Effect
Active Publication Date: 2010-07-07
LUNAN PHARMA GROUP CORPORATION
View PDF3 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0004] In the current process of clinical hypertension drug treatment, the reduction of systolic blood pressure is one of the difficulties in the treatment of hypertension, especially for many elderly hypertensive patients, it is difficult to lower the systolic blood pressure
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
[0034] Preparation process: It is prepared according to the conventional process of tablets.
Embodiment 3
[0035] Embodiment 3 hypertension compound capsule
[0036] Isosorbide Mononitrate 25g
[0037] Irbesartan 600g
[0038] Spironolactone 0.3g
[0039] Lactose 20g
[0040] Microcrystalline Cellulose 30g
[0041] Sodium carboxymethyl starch 5g
[0042] 10% starch slurry appropriate amount
[0043] Preparation process: Pass isosorbide mononitrate, irbesartan, spironolactone, lactose, microcrystalline cellulose and sodium carboxymethyl starch in the prescription through a 100-mesh sieve, mix well, add 10% starch slurry to granulate in an appropriate amount, Dry below 60°C, sieve through a 18-mesh sieve, and fill the capsules.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a drug composition for curing cardiovascular system diseases and the key point is that the invention which combines sartans, aldosterone receptor antagonist and isosorbide mononitrate according to certain proportions becomes a novel drug which cures the cardiovascular system diseases such as hypertension and heart failures and achieves ideal treatment effects comprehensively considered. The invention has the advantages that 1. The invention has a good effect in anti-myocardial fibrosis anti-ventricular hypertrophy as well as effective antihypertensive. 2. The invention is good in treating simple systolic hypertension of the elderly, exact in hypertensive effect, stable in operation and has no drug resistance. 3. The invention has active influences on the prognosisof patients of hypertension and the related complications, which is also the most meaningful clinical treatment problems which are solved by the invention.
Description
Technical field [0001] The invention relates to a pharmaceutical composition for treating hypertension. Background technique [0002] Cardiovascular disease is a kind of disease that seriously endangers human health. With the advancement of society and the improvement of human living standards, the incidence of such diseases has increased year by year, becoming the number one killer threatening human health. Hypertension, as the most common cardiovascular disease, has an increasing incidence and a trend of younger age. Various complications caused by hypertension, such as myocardial hypertrophy, myocardial fibrosis, heart failure, myocardial ischemia and arrhythmia, are important reasons for the decline in the quality of life and long-term survival of hypertensive patients. This has aroused the great attention of medical workers. After continuous and in-depth research on the pathogenesis of hypertension, great achievements have been made in the etiology, pathology, physiol...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more